Celularity INC Form 4 insider transactions

Stephen Brigido, Pres. of Functional Regeneration at Celularity Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Celularity Inc. CFO David Beers reports the vesting of restricted stock units (RSUs) and subsequent stock transactions.

Senior Executive Vice President John R. Haines reports the vesting of restricted stock units (RSUs) and subsequent stock transactions.

Lim Kok Thay, along with Dragasac Limited and Genting Berhad, reports transactions involving Class A Common Stock and warrant amendments related to Celularity Inc.

Director Diane L. Parks reports the acquisition of restricted stock units and stock options in Celularity Inc.

Director Geoffrey Ling of Celularity Inc. reports the vesting of restricted stock units and the grant of stock options.

Director Richard J. Berman reports the acquisition of restricted stock units and stock options in Celularity Inc.

Director Dean C. Kehler reports acquisition of restricted stock units and stock options in Celularity Inc.

Director Peter Diamandis reports the acquisition of restricted stock units and stock options in Celularity Inc.

Genting Berhad and Lim Kok Thay report the acquisition of 1,350,000 warrants in Celularity Inc., exercisable at $2.988 per share, along with a correction of previous filings regarding direct share ownership.

Director Richard J Berman received a stock option grant from Celularity Inc on August 27, 2024.

Executive Vice President and General Counsel of Celularity Inc., Kyle Fletcher, reports the withholding of shares to cover tax obligations related to vested restricted stock units.

John R. Haines, a Senior EVP at Celularity Inc., reports the withholding of shares to cover tax obligations related to vested restricted stock units.

David C. Beers, CFO of Celularity Inc., disposed of 360 shares of Class A Common Stock on April 13, 2024, to cover tax obligations related to vesting restricted stock units.

Celularity Inc. CEO Robert J. Hariri disposed of 1,154 shares of Class A Common Stock to cover tax obligations related to the vesting of restricted stock units.

Stephen Brigido, President of Functional Regeneration at Celularity Inc., reports the withholding of shares to cover tax obligations related to vested restricted stock units.

Kyle Fletcher, Executive Vice President and General Counsel of Celularity Inc., reports the withholding of shares to cover tax obligations related to vested restricted stock units.

Celularity Inc. issued 300,000 warrants to Resorts World Inc. Pte. Ltd. as consideration for a forbearance agreement related to an existing loan.